| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |